Skip to main content
Explore URMC

menu

Multiple Myeloma or Lymphoma: Study of CLR 131 in Relapsed or Refractory Select B-Cell Malignancies

Research Question:
Is the study drug, CLR 131, effective for the treatment of multiple myeloma or certain lymphomas?

Basic Study Information

Purpose:
This research is being done to help us determine if the study drug is safe and can be tolerated for the treatment of multiple myeloma or certain lymphomas.

Location: Cancer Center
Study Web URL:  https://clinicaltrials.gov/ct2/show/NCT02952508?term=02952508&rank=1
Study Reference #: IMMY17015

Lead Researcher (Principal Investigator)

Lead Researcher: Brea Lipe

Study Contact Information

Study Coordinator: Andrew Bui
Phone: (585) 276-4405
Email: Andrew_Bui@URMC.Rochester.edu

Additional Study Details

Learn More About These Conditions

More information about Lymphoma

More information about Multiple Myeloma

Return to Search